Want to use our logo?

Download the ICS Branding Pack

ICS Background

Dr David R Staskin
Tufts University School of Medicine

View Member Details

David Staskin


You must be logged in to view this contact
to ICS

Dr. Staskin has also served as a member: HHS Incontinence Guidelines (panel) ICI Guidelines for Incontinence (Chairperson) Initial Evaluation x2 Conservative Therapies x1 AUA Guidelines: “Surgical Management of Stress Urinary Incontinence.” (panel) Society for Urodynamics and Female Urology (past Board of Directors) American Urogynecological Society (AUGS) (past Board of Directors) American Association Clinical Urologists / UROPAC (past Board of Directors)

Dr. Staskin also serves on the follow journals as a reviewer or editor: International Urogynecology (past editorial Board) Current Urology Reports (past editorial Board) Journal of Urology (reviewer) Urology (reviewer) Neurourology and Urodynamics (reviewer) British Journal Urology International (reviewer) New England Journal of Medicine (reviewer) Nature Urology (reviewer) Int. Journal of Clinical Practice (reviewer)

Dr. Staskin has published extensively (> 145 articles) in the areas of female urology, male voiding dysfunction, BPH and LUTS, neuro-urology, and urodynamics. He is an editor of the textbooks - Textbook of Female Urology and Urogynecology 4th edition. (eds. Cardozo and Staskin) – Atlas of Bladder Diseases (ed. Staskin) and Interstitial Cystitis (eds. Hanno, Staskin, Wein, Krane) – Bladder Pain Syndrome – IC (eds. Hanno, Staskin et.al.)

Dr. Staskin has lectured nationally and internationally on topics related to voiding dysfunction in female and male patients. He has chaired multiple symposia on uropharmacology at the ICS meetings, AUA, and EAU.

Dr. Staskin holds multiple device patents (67) and is the inventor of several mid-urethral slings and pelvic prolapse products.

Dr David R Staskin declared on the Friday 7th April 2017 that they had the following existing or known future financial relationships or affiliations:


  • Consultant


  • Consultant


  • Consultant

Roivant Pharma

  • Consultant


  • Consultant

Sling Patents

  • Owner


  • Equity Interests

BB2 pharma

  • Equity Interests


  • Consultant
  • Speaker Honorarium


  • Consultant
  • Speaker Honorarium